| __timestamp | Gilead Sciences, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2854000000 | 4101058 |
| Thursday, January 1, 2015 | 3014000000 | 10763215 |
| Friday, January 1, 2016 | 5098000000 | 5579049 |
| Sunday, January 1, 2017 | 3734000000 | 32051299 |
| Monday, January 1, 2018 | 5018000000 | 24482286 |
| Tuesday, January 1, 2019 | 9106000000 | 43892589 |
| Wednesday, January 1, 2020 | 5039000000 | 44505000 |
| Friday, January 1, 2021 | 5363000000 | 79406000 |
| Saturday, January 1, 2022 | 4977000000 | 49283000 |
| Sunday, January 1, 2023 | 6923000000 | 17282730 |
| Monday, January 1, 2024 | 5907000000 |
Cracking the code
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Gilead Sciences, Inc. and Verona Pharma plc, two prominent players in the industry, showcase contrasting approaches to R&D investment over the past decade.
From 2014 to 2023, Gilead Sciences consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2019 at approximately $9.1 billion. This represents a staggering 220% increase from their 2014 spending. In contrast, Verona Pharma's R&D spending, while modest in comparison, saw a remarkable growth of over 1,800% during the same period, reaching its highest in 2021.
These figures highlight Gilead's robust financial commitment to innovation, while Verona Pharma's exponential growth in R&D investment underscores its strategic focus on expanding its research capabilities.
AbbVie Inc. or Gilead Sciences, Inc.: Who Invests More in Innovation?
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Novartis AG and Gilead Sciences, Inc.
R&D Insights: How Gilead Sciences, Inc. and Axsome Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Bio-Techne Corporation vs Verona Pharma plc
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Research and Development Investment: Verona Pharma plc vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.